Action FLERIE FLERIE INVEST AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Flerie Invest AB

Actions

FLERIE

SE0008966295

Marché Fermé - Nasdaq Stockholm
Autres places de cotation
 18:00:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
0,472 SEK -1,67 % Graphique intraday de Flerie Invest AB -5,41 % +84,38 %
14/06 Alligator Bioscience nomme un nouveau directeur financier MT
10/06 Flerie Invest AB a finalisé l'acquisition d'InDex Pharmaceuticals Holding AB (publ) auprès d'un groupe d'actionnaires. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Flerie AB(OM:FLERIE) added to OMX Nordic All-Share Index
Alligator Bioscience Names New CFO
InDex Pharmaceuticals Holding AB will Change its Name to Flerie AB
InDex Pharmaceuticals completes reverse merger with Flerie
Bulletin from the Extraordinary General Meetings in InDex Pharmaceuticals Holding AB (publ) on June 10, 2024
Flerie Invest AB completed the acquisition of InDex Pharmaceuticals Holding AB (OM:INDEX) from group of shareholders.
InDex Pharmaceuticals Gets OK to Keep Nasdaq First North Growth Market Listing Amid Reverse Takeover, Uplisting Plans
InDex Pharmaceuticals has received a conditional approval for continued listing on Nasdaq First North Growth Market after the reverse merger of Flerie
InDex Pharmaceuticals publishes NAV for Flerie as of May 31, 2024
InDex Pharmaceuticals publishes company description in connection with the reverse merger of Flerie
Flerie makes its way to the stock market via InDex
Global markets live: Microsoft, Roche, BMW, Nintendo, Nordson...
Borsa di Italia: tecnologia in orbita
Bolsa de Madrid: Tecnología en órbita
InDex Pharmaceuticals to Buy Flerie Invest Under Reverse Merger Plan
InDex Pharmaceuticals has entered into a conditional agreement regarding a reverse merger with Flerie
Bulletin from the Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)
InDex Pharmaceuticals Holding AB Approves the Election of Karl Tobieson as Board Member
Notice of extraordinary general meeting in InDex Pharmaceuticals Holding AB (publ)
InDex Pharmaceuticals provides a status update and informs about Extraordinary General Meeting on June 10, 2024
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action FLERIE
  4. Actualités Flerie Invest AB
  5. Autres langues